Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Atousa Ataei"'
Autor:
Atousa Ataei, Niloufar Seyed Majidi, Javad Zahiri, Mehrdad Rostami, S. Shahriar Arab, Albert A. Rizvanov
Publikováno v:
Journal of Big Data, Vol 8, Iss 1, Pp 1-21 (2021)
Abstract Most of the current cancer treatment approaches are invasive along with a broad spectrum of side effects. Furthermore, cancer drug resistance known as chemoresistance is a huge obstacle during treatment. This study aims to predict the resist
Externí odkaz:
https://doaj.org/article/d59c9afaf2f1488aad436b49fc3d2533
Autor:
Javad Zahiri, Niloufar Seyed Majidi, Mehrdad Rostami, Atousa Ataei, Albert A. Rizvanov, Seyed Shahriar Arab
Publikováno v:
Journal of Big Data, Vol 8, Iss 1, Pp 1-21 (2021)
Most of the current cancer treatment approaches are invasive along with a broad spectrum of side effects. Furthermore, cancer drug resistance known as chemoresistance is a huge obstacle during treatment. This study aims to predict the resistance of s
Publikováno v:
Iranian Journal of Biotechnology
Background: The details of molecular mechanisms underlying the differentiation of Mesenchymal Stem Cells (MSCs) into specific lineages are not well understood. Objectives: We aimed to construct the interactome network and topology analysis of bone ma
Autor:
Sepehr Torabinejad, Mohammad Foad Abazari, Parisa Pazooki, Abbas Ardalan, Hassan Askari, Mansour Poorebrahim, Hanieh Bokharaei, Navid Negaresh, Maryam Nouri Aleagha, Vahdat Poortahmasebi, Matin Asghari, Atousa Ataei
Publikováno v:
Future Science OA
Aim: Until now, identification of drug targets for treatment of patients with specific stages of colorectal cancer (CRC) has remained a challenging field of research. Herein, we aimed to identify the key genes and regulatory networks involved in each
Autor:
Ali Salarian, Matin Asghari, Seyed Mohammad Jazayeri, Mansour Poorebrahim, Mehdi Amiri, Vahdat Poortahmasebi, Seyed Moayed Alavian, Atousa Ataei
Publikováno v:
Hepatitis Monthly. 17
Background: The natural history of chronic hepatitis B (CHB) infection is divided into different phases including immune tolerance (IT), immune clearance (or immune active [IA]), inactive carrier (IC), and reactivation. Despite utilizing high-through
Autor:
Maryam Nouri Aleagha, Atousa Ataei, Saeideh Najafi, Mohammad Nasr Dadras, Mansour Poorebrahim, Mohammad Foad Abazari, Vahdat Poortahmasebi, Seyed Mohammad Jazayeri, Ali Salarian
Publikováno v:
Archives of virology. 162(5)
Epstein-Barr virus (EBV) is the most common cause of infectious mononucleosis (IM) and establishes lifetime infection associated with a variety of cancers and autoimmune diseases. The aim of this study was to develop an integrative gene regulatory ne